{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:19:47Z","timestamp":1791271187571,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11904-020-00523-0","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T11:27:00Z","timestamp":1597404420000},"page":"478-486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study"],"prefix":"10.1007","volume":"17","author":[{"given":"Shahin","family":"Lockman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly Pretorius","family":"Holme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Makhema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Bachanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refeletswe","family":"Lebelonyane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Essex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"issue":"11","key":"523_CR1","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1097\/QAD.0b013e32832b7dca","volume":"23","author":"S Attia","year":"2009","unstructured":"Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS. 2009;23(11):1397\u2013404. https:\/\/doi.org\/10.1097\/QAD.0b013e32832b7dca.","journal-title":"AIDS."},{"issue":"16","key":"523_CR2","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1097\/QAD.0b013e328312c756","volume":"22","author":"K Modjarrad","year":"2008","unstructured":"Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS. 2008;22(16):2179\u201385. https:\/\/doi.org\/10.1097\/QAD.0b013e328312c756.","journal-title":"AIDS."},{"key":"523_CR3","doi-asserted-by":"publisher","unstructured":"Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342(13):921\u2013929. doi:https:\/\/doi.org\/10.1056\/NEJM200003303421303.","DOI":"10.1056\/NEJM200003303421303"},{"key":"523_CR4","doi-asserted-by":"publisher","unstructured":"Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C, Lew JF Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999;341(6):394\u2013402. doi:https:\/\/doi.org\/10.1056\/NEJM199908053410602.","DOI":"10.1056\/NEJM199908053410602"},{"key":"523_CR5","doi-asserted-by":"publisher","unstructured":"Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, 3rd, Whitehouse J et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999;341(6):385\u2013393. doi:https:\/\/doi.org\/10.1056\/NEJM199908053410601.","DOI":"10.1056\/NEJM199908053410601"},{"issue":"6","key":"523_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505. https:\/\/doi.org\/10.1056\/NEJMoa1105243.","journal-title":"N Engl J Med"},{"issue":"9","key":"523_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1600693.","journal-title":"N Engl J Med"},{"key":"523_CR8","doi-asserted-by":"publisher","unstructured":"Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet (London, England). 2019;393(10189):2428\u201338. doi:https:\/\/doi.org\/10.1016\/s0140-6736(19)30418-0.","DOI":"10.1016\/s0140-6736(19)30418-0"},{"issue":"2","key":"523_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2016.5148","volume":"316","author":"AJ Rodger","year":"2016","unstructured":"Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. Jama. 2016;316(2):171\u201381. https:\/\/doi.org\/10.1001\/jama.2016.5148.","journal-title":"Jama."},{"key":"523_CR10","doi-asserted-by":"publisher","unstructured":"Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (London, England). 2009;373(9657):48\u201357. doi:https:\/\/doi.org\/10.1016\/S0140-6736(08)61697-9.","DOI":"10.1016\/S0140-6736(08)61697-9"},{"key":"523_CR11","volume-title":"90-90-90: an ambitious treatment target to help end the AIDS epidemic","author":"UNAIDS","year":"2014","unstructured":"UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. UNAIDS: Geneva, Switzerland; 2014."},{"issue":"7","key":"523_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001245","volume":"9","author":"JW Eaton","year":"2012","unstructured":"Eaton JW, Johnson LF, Salomon JA, Barnighausen T, Bendavid E, Bershteyn A, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9(7):e1001245. https:\/\/doi.org\/10.1371\/journal.pmed.1001245.","journal-title":"PLoS Med"},{"key":"523_CR13","doi-asserted-by":"publisher","unstructured":"\u2022 Perriat D, Balzer L, Hayes R, Lockman S, Walsh F, Ayles H et al. Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa. Journal of the International AIDS Society. 2018;21(1). doi:https:\/\/doi.org\/10.1002\/jia2.25048. This paper provides a comparative assessment of the designs of the UTT trials discussed in this review.","DOI":"10.1002\/jia2.25048"},{"key":"523_CR14","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K et al. Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART). N Engl J Med. 2019;381(3):207\u201318. doi:https:\/\/doi.org\/10.1056\/NEJMoa1814556. This paper presents the primary results on HIV incidence, and viral suppression and intervention coverage from the HPTN 071 (PopART) trial conducted in South Africa and Zambia.","DOI":"10.1056\/NEJMoa1814556"},{"key":"523_CR15","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Havlir DV, Balzer LB, Charlebois ED, Clark TD, Kwarisiima D, Ayieko J et al. HIV testing and treatment with the use of a community health approach in rural Africa. N Engl J Med. 2019;381(3):219\u201329. doi:https:\/\/doi.org\/10.1056\/NEJMoa1809866. This paper presents the primary results on HIV incidence and community health outcomes from the SEARCH trial conducted in Kenya and Uganda.","DOI":"10.1056\/NEJMoa1809866"},{"key":"523_CR16","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. The Lancet HIV. 2018;5(3):e116-e25. doi:https:\/\/doi.org\/10.1016\/s2352-3018(17)30205-9. This paper presents the primary results on HIV incidence and coverage of HIV diagnosis, treatment, and viral suppression in the TasP\/ANRS 12249 trial conducted in Kwa-Zulu Natal, South Africa.","DOI":"10.1016\/s2352-3018(17)30205-9"},{"key":"523_CR17","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E et al. Universal testing, expanded treatment, and incidence of HIV infection in Botswana. N Engl J Med. 2019;381(3):230\u201342. doi:https:\/\/doi.org\/10.1056\/NEJMoa1812281. This paper presents the primary results on impact on HIV incidence from the Botswana Combination Prevention Project\/\u201cYa Tsie\u201d trial conducted in Botswana.","DOI":"10.1056\/NEJMoa1812281"},{"issue":"9","key":"523_CR18","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807. https:\/\/doi.org\/10.1056\/NEJMoa1506816.","journal-title":"N Engl J Med"},{"issue":"9","key":"523_CR19","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa1507198","volume":"373","author":"C Danel","year":"2015","unstructured":"Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, et al. A trial of early Antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1507198.","journal-title":"N Engl J Med"},{"key":"523_CR20","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva, Switzerland: World Health Organization 2016."},{"key":"523_CR21","unstructured":"Probert W. Model projections of the impact of the PopART intervention in the HPTN 071 (PopART) study. Abstract MOSY0303. International AIDS Society; July 21-24, 2019; Mexico City, Mexico."},{"key":"523_CR22","doi-asserted-by":"publisher","unstructured":"Camlin CS, Akullian A, Neilands TB, Getahun M, Eyul P, Maeri I et al. Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial. Journal of the International AIDS Society. 2018;21 Suppl 4:e25115. doi:https:\/\/doi.org\/10.1002\/jia2.25115.","DOI":"10.1002\/jia2.25115"},{"key":"523_CR23","unstructured":"Mmalane MO, Moyo S, Sento B, Leidner J, Bennett K, Phindele T et al. Association of Mobility with HIV Recent Infections and Viremia in Botswana. Abstract #936. Conference on Retroviruses and Opportunistic Infections; March 4\u20137, 2018; Boston, MA, USA."},{"key":"523_CR24","doi-asserted-by":"publisher","unstructured":"\u2022 Alwano MG, Bachanas P, Block L, Roland M, Sento B, Behel S et al. Increasing knowledge of HIV status in a country with high HIV testing coverage: results from the Botswana Combination Prevention Project. PLoS One. 2019;14(11):e0225076. doi:https:\/\/doi.org\/10.1371\/journal.pone.0225076. This paper presents the results of the Botswana Combination Prevention Project\/Ya Tsie trial\u2019s multi-modality HIV testing approach targeted to identify \u2265 90% of people living with HIV in the intervention communities.","DOI":"10.1371\/journal.pone.0225076"},{"issue":"4","key":"523_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10461-019-02408-9","volume":"23","author":"A Lasry","year":"2019","unstructured":"Lasry A, Bachanas P, Suraratdecha C, Alwano MG, Behel S, Pals S, et al. Cost of community-based HIV testing activities to reach saturation in Botswana. AIDS Behav. 2019;23(4):875\u201382. https:\/\/doi.org\/10.1007\/s10461-019-02408-9.","journal-title":"AIDS Behav"},{"key":"523_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540121.2019.1640843","volume":"32","author":"P Kebaabetswe","year":"2019","unstructured":"Kebaabetswe P, Manyake K, Kadima E, Auletta-Young C, Chakalisa U, Sekoto T, et al. Barriers and facilitators to linkage to care and ART initiation in the setting of high ART coverage in Botswana. AIDS Care. 2019;32:1\u20137. https:\/\/doi.org\/10.1080\/09540121.2019.1640843.","journal-title":"AIDS Care"},{"key":"523_CR27","unstructured":"Lebelonyane R, Mills LA, Mogorosi C, Wang H, Marukutira T, Theu J et al. Advanced HIV and the care cascade in the Botswana Combination Prevention Project. Abstract 887. Conference on Retroviruses and Opportunistic Infections; March 4-7, 2018; Boston, MA, USA."},{"issue":"5","key":"523_CR28","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/S2352-3018(16)00037-0","volume":"3","author":"T Gaolathe","year":"2016","unstructured":"Gaolathe T, Wirth KE, Holme MP, Makhema J, Moyo S, Chakalisa U, et al. Botswana\u2019s progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. The Lancet HIV. 2016;3(5):e221\u201330. https:\/\/doi.org\/10.1016\/S2352-3018(16)00037-0.","journal-title":"The Lancet HIV"},{"key":"523_CR29","unstructured":"Bachanas P, Alwano MG, Lebelonyane R, Block L, Behel S, Raizes E et al. What does it take to reach and sustain 90-90-90? Bridging the Gaps in the HIV Care Cascade in the Botswana Combination Prevention Project. [unpublished manuscript 2020]."},{"key":"523_CR30","unstructured":"Moore J. Accelerating the uptake of treatment: Botswana Combination Prevention Project. [unpublished presentation 2018]."},{"key":"523_CR31","unstructured":"Lebelonyane R, Bachanas P, Abrams W, Roland M, Theu J, Kapanda M et al. Fast-track ART initiation in Botswana is associated with high rates of ART initiation, retention in care, and virological suppression. Abstract THAC0404. AIDS 2018: 22nd international AIDS Conference; July 23\u201327, 2018; Amsterdam, The Netherlands."},{"key":"523_CR32","doi-asserted-by":"crossref","unstructured":"\u2022 Lebelonyane R, Bachanas P, Block L, Ussery F, Abrams W, Roland M et al. Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before-and-after study. [Manuscript. The Lancet HIV]. In press 2020. This paper presents a comparison of time to ART initiation, retention in care, and viral suppression before and after the implementation of a rapid ART initation intervention in the Botswana Combination Prevention Project\/Ya Tsie trial.","DOI":"10.1016\/S2352-3018(20)30187-9"},{"key":"523_CR33","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Wirth K, Gaolathe T, Pretorius Holme M, Mmalane M, Kadima E, Chakalisa U et al. Population uptake of HIV testing, treatment, viral suppression, and male circumcision in Botswana: a cluster-randomized trial. Lancet HIV. 2020;7(6):e422\u201333. https:\/\/doi.org\/10.1016\/S2352-3018(20)30103-X. This paper presents the primary results of intervention coverage by randomized arm in the Botswana Combination Prevention Project\/Ya Tsie trial.","DOI":"10.1016\/S2352-3018(20)30103-X"},{"key":"523_CR34","unstructured":"Ussery F, Bachanas P, Alwano MG, Lebelonyane R, Block L, Wirth K et al. High HIV incidence in young women in the Botswana Combination Prevention Project. Abstract 149. Conference on Retroviruses and Opportunistic Infections; March 8-11, 2020; Boston, MA, USA."}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-020-00523-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-020-00523-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-020-00523-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T22:52:29Z","timestamp":1667775149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-020-00523-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["523"],"URL":"https:\/\/doi.org\/10.1007\/s11904-020-00523-0","relation":{},"ISSN":["1548-3568","1548-3576"],"issn-type":[{"value":"1548-3568","type":"print"},{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"14 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies with human subjects performed by the authors have complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines). The Botswana Combination Prevention Project (NCT01965470) was approved by IRBs at the U.S. Centers for Disease Control and Prevention and the Botswana Ministry of Health and Wellness.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}